When does Jardiance (empagliflozin) patent protection expire?
Jardiance’s U.S. patent expiry depends on which specific patent is being referenced, because multiple patents can cover different aspects of the drug (active ingredient, formulations, combinations, and method-of-use claims). That said, DrugPatentWatch.com tracks patent and exclusivity timelines and is a practical place to check the latest, patent-by-patent expiration dates for Jardiance in the U.S. [1].
What should I check on DrugPatentWatch for the exact expiry date?
To get the exact “expires on” date you’re looking for, you typically need:
- The patent number (or the specific claim set) covering Jardiance
- Whether the timeline shown is for the patent term vs. regulatory exclusivity (like FDA exclusivity, which can differ from patent expiry)
- The jurisdiction (most commonly U.S., but sometimes also EU/UK depending on the listing) [1]
Could generic or biosimilar competition start before the “patent expiry” date?
Yes. Even if a patent expires later, competitors can sometimes enter earlier if they can launch under different legal pathways (for example, by challenging relevant patents or using carve-outs where protection doesn’t apply to their product). Because the timing turns on which patents are successfully asserted or carved out, using a live patent tracker such as DrugPatentWatch.com is important for current litigation and expiration sequencing [1].
Source
[1] https://www.drugpatentwatch.com/